Delivery Order SPE2DB22D1017-SPE2DB24FF5MN
Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $8.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $98,647.61 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 24,000 units of the pharmaceutical product CREON DR 24,000 UNIT CAPSULE. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award, which is not subject to any set-aside designation. Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,317.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 36,000 unit capsules of the pharmaceutical product Creon DR 100s. The contract has a completion date of February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not designated as a set-aside contract. In addition, Amerisourcebergen Drug Corp holds an...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,507.01 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 36,000 unit capsules of the pharmaceutical product CREON DR 100s. The contract has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order contract is associated with a larger indefinite...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 36,000 units of CREON DR 4563849287 capsules in 100-count packages. The potential value of this contract is $1,366.89 with a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This delivery order is part of a larger indefinite...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $7,182.46 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, which has an ultimate completion date of April 3, 2024, is for the delivery of 36,000 unit capsules of the medication CREON DR 100s. This delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 24,000 unit capsules of CREON DR 100S medication. The contract, valued at $4,686.48, has a period of performance through March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is a child contract under a larger $999,999,999.00 indefinite delivery contract (IDC) the company holds...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,171.68 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The delivery order is for 36,000 units of Creon DR 100s capsules, a brand-name medication. This delivery order was issued against an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was awarded a $2,343.24 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 36,000 units of the prescription drug Creon DR (100 capsules per bottle) with a completion date of February 14, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen holds with DLA to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $35,990.52 order is for the delivery of 24,000 unit capsules of the pharmaceutical product Creon DR. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary contract vehicle for the company to deliver...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a delivery order with a firm fixed price valued at $10,355.11. The award is for the supply of 36,000 unit capsules of the pharmaceutical product Creon DR to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF5MNDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 24,000 units of the pharmaceutical product Creon DR in 100-count capsule bottles. The $8,452.28 contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 that serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Generated 7/5/24, 9:31 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 4/5/24 |